Literature DB >> 18985712

Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children.

Devendra K Amre1, David R Mack, Kenneth Morgan, Alfreda Krupoves, Irina Costea, Philippe Lambrette, Guy Grimard, Jinsong Dong, Houda Feguery, Vytautas Bucionis, Colette Deslandres, Emile Levy, Ernest G Seidman.   

Abstract

BACKGROUND: Recent genome-wide studies have implicated the autophagy genes ATG16L1 and IRGM in the pathogenesis of Crohn's disease (CD). We investigated whether these genes were associated with CD in Canadian children.
METHODS: A case-control study was carried out at 2 pediatric gastroenterology clinics in Canada. Confirmed cases of CD <20 years diagnosed using standard criteria were classified according to the Montreal Classification scheme. Single nucleotide polymorphisms (SNPs) rs2241880 (ATG16L1) and rs10065172 (IRGM) along with CARD15 SNPs, SNP8, SNP12, and SNP13 were genotyped.
RESULTS: A total of 289 CD cases and 290 controls were studied. The mean age (+/-SD) of the cases was 12.1 (+/-3.5) years of age. Most cases were male (55.4%), had disease location L3 +/- L4 (56.7%), and an inflammatory phenotype B1 +/- p (87.2%) at diagnosis. rs2241880 (ATG16L1) was strongly associated with CD (allelic P = 1.24 x 10(-6)). Children with GG genotype had a more than 3-fold elevated risk for disease as compared to the wildtype AA homozygotes (odds ratio [OR], 3.1; 95% confidence interval [CI], 1.93-4.94; P = 1.8 x 10(-6)). Association with SNP rs2241880 was specific for ileal disease (with or without colonic involvement) (case-based allelic P = 0.02; P-value versus controls = 9.5 x 10(-8)). The frequency of IRGM SNP rs10065172 was higher in cases but differences with controls were not statistically significant. No interactions between CARD15 and either ATG16L1 or IRGM were evident.
CONCLUSIONS: We have confirmed associations between CD and ATG16L1 in a pediatric cohort of Canadian children. Associations with IRGM need to be further evaluated in larger studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18985712     DOI: 10.1002/ibd.20785

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  21 in total

1.  Association between genome-wide association studies reported SNPs and pediatric-onset Crohn's disease in Canadian children.

Authors:  Devendra K Amre; David R Mack; Kenneth Morgan; David Israel; Colette Deslandres; Ernest G Seidman; Phlippe Lambrette; Irina Costea; Alfreda Krupoves; Houda Fegury; Jinsong Dong; Zia Xhu; Guy Grimard; Emile Levy
Journal:  Hum Genet       Date:  2010-05-16       Impact factor: 4.132

2.  NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients.

Authors:  Nora Meggyesi; Lajos S Kiss; Magdalena Koszarska; Martin Bortlik; Dana Duricova; Laszlo Lakatos; Tamas Molnar; Martin Leniček; Libor Vítek; Istvan Altorjay; Maria Papp; Zsolt Tulassay; Pal Miheller; Janos Papp; Attila Tordai; Hajnalka Andrikovics; Milan Lukas; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

Review 3.  ATG16L1: A multifunctional susceptibility factor in Crohn disease.

Authors:  Mohammad Salem; Mette Ammitzboell; Kris Nys; Jakob Benedict Seidelin; Ole Haagen Nielsen
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

Review 4.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

Review 5.  Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility.

Authors:  Byong Duk Ye; Dermot P B McGovern
Journal:  Expert Rev Clin Immunol       Date:  2016-06-15       Impact factor: 4.473

6.  Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn's disease.

Authors:  S Dionne; M R Calderon; J H White; B Memari; I Elimrani; B Adelson; C Piccirillo; E G Seidman
Journal:  Mucosal Immunol       Date:  2014-04-30       Impact factor: 7.313

7.  T300A polymorphism of ATG16L1 and susceptibility to inflammatory bowel diseases: a meta-analysis.

Authors:  Jia-Fei Cheng; Yue-Ji Ning; Wei Zhang; Zong-Hai Lu; Lin Lin
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

8.  Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort.

Authors:  Josef Wagner; Winnie H Sim; Justine A Ellis; Eng K Ong; Anthony G Catto-Smith; Donald J S Cameron; Ruth F Bishop; Carl D Kirkwood
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

9.  Genome-wide association studies--a summary for the clinical gastroenterologist.

Authors:  Espen Melum; Andre Franke; Tom H Karlsen
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

10.  ATG16L1 T300A polymorphism and Crohn's disease susceptibility: evidence from 13,022 cases and 17,532 controls.

Authors:  Hai-Feng Zhang; Li-Xin Qiu; Yu Chen; Wa-Li Zhu; Chen Mao; Li-Guang Zhu; Ming-Hua Zheng; Yan Wang; Lei Lei; Jian Shi
Journal:  Hum Genet       Date:  2009-04-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.